down arrow

Allurion Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02008G1022
USD
1.73
0.05 (2.98%)

Dec 09

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Cerus Corp.
NeuroPace, Inc.
Sanara MedTech, Inc.
Anika Therapeutics, Inc.
ZimVie, Inc.
AVITA Medical, Inc.
Allurion Technologies, Inc.
Accuray, Inc.
Zynex, Inc.
Pulse Biosciences, Inc.
Alpha Tau Medical Ltd.
Why is Allurion Technologies, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -13.96
  • The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Negative results in Jun 25
  • RAW MATERIAL COST(Y) Grown by 11.18% (YoY)
  • NET SALES(Q) Lowest at USD 3.38 MM
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -81.64%, its profits have risen by 56.2%
4
Below par performance in long term as well as near term
  • Along with generating -81.64% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Allurion Technologies, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Allurion Technologies, Inc.
-81.64%
-0.50
189.36%
S&P 500
12.42%
0.62
20.18%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
175.54%
EBIT Growth (5y)
-354.50%
EBIT to Interest (avg)
-13.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
0.14
Tax Ratio
3.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.21%
ROCE (avg)
0
ROE (avg)
0.72%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.29
EV to EBIT
-0.82
EV to EBITDA
-0.84
EV to Capital Employed
-0.54
EV to Sales
1.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -41.81 MM

NET PROFIT(HY)

Higher at USD -10.06 MM

-13What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 11.18% (YoY

NET SALES(Q)

Lowest at USD 3.38 MM

Here's what is working for Allurion Technologies, Inc.
Net Profit
Higher at USD -10.06 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Profit
At USD -10.06 MM has Grown at 53.01%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD -41.81 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Here's what is not working for Allurion Technologies, Inc.
Net Sales
At USD 3.38 MM has Fallen at -52.25%
over average net sales of the previous four periods of USD 7.08 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Net Sales
Lowest at USD 3.38 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Raw Material Cost
Grown by 11.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."